Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Loss of Heterozygosity in the Tumor DNA of De Novo Diagnosed Patients Is Associated with Poor Outcome for B-ALL but Not for T-ALL.
Risinskaya N, Kozhevnikova Y, Gavrilina O, Chabaeva J, Kotova E, Yushkova A, Isinova G, Zarubina K, Obukhova T, Kulikov S, Julhakyan H, Sudarikov A, Parovichnikova E. Risinskaya N, et al. Among authors: obukhova t. Genes (Basel). 2022 Feb 23;13(3):398. doi: 10.3390/genes13030398. Genes (Basel). 2022. PMID: 35327952 Free PMC article.
[Acute Ph-negative lymphoblastic leukemias in adults: Risk factors in the use of the ALL-2009 protocol].
Parovichnikova EN, Sokolov AN, Troitskaya VV, Klyasova GA, Rusinov MA, Akhmerzaeva ZK, Kuzmina LA, Bondarenko SN, Baranova OY, Kaporskaya TS, Zotina EN, Zinina EE, Samoilova OS, Gavrilova LV, Kaplanov KD, Konstantinova TS, Lapin VA, Kravchenko SK, Gribanova EO, Zvonkov EE, Gavrilina OA, Baskhaeva GA, Galstyan GM, Obukhova TN, Galtseva IV, Kulikov SM, Savchenko VG. Parovichnikova EN, et al. Among authors: obukhova tn. Ter Arkh. 2016;88(7):15-24. doi: 10.17116/terarkh201688715-24. Ter Arkh. 2016. PMID: 27459610 Russian.
[Hepatosplenic T-cell lymphoma: The problems of diagnosis and treatment].
Chernova NG, Julhakyan HL, Vinogradova YE, Sidorova YV, Ryzhikova NV, Korzhova SM, Sinitsyna MN, Tikhomirov DS, Naumova EV, Obukhova TN, Dvirnyk VN, Sudarikov AB, Kovrigina AM, Kravchenko SK, Melikyan AL, Kuzmina LA, Galtseva IV, Smirnova SY, Gemdzhian EG, Zvonkov EE, Parovichnikova EN, Savchenko VG. Chernova NG, et al. Among authors: obukhova tn. Ter Arkh. 2016;88(7):4-14. doi: 10.17116/terarkh20168874-14. Ter Arkh. 2016. PMID: 28635923 Russian.
[Adult B-cell acute lymphoblastic leukemias: Conclusions of the Russian prospective multicenter study ALL-2009].
Parovichnikova EN, Troitskaya VV, Sokolov AN, Bondarenko SN, Gavrilina OA, Baskhaeva GA, Biderman BV, Lukyanova IA, Kuz'mina LA, Klyasova GA, Kravchenko SK, Gribanova EO, Zvonkov EE, Akhmerzaeva ZK, Baranova OY, Kaporskaya TS, Ryltsova TV, Zotina EN, Zinina EE, Samoilova OS, Kaplanov KD, Gavrilova LV, Konstantinova TS, Lapin VA, Pristupa AS, Eluferyeva AS, Obukhova TN, Piskunova IS, Gal'tseva IV, Dvirnyk VN, Rusinov MA, Kulikov SM, Savchenko VG. Parovichnikova EN, et al. Among authors: obukhova tn. Ter Arkh. 2017;89(7):10-17. doi: 10.17116/terarkh201789710-17. Ter Arkh. 2017. PMID: 28766535 Clinical Trial. Russian.
[Prognostic value of 1q21 amplification in multiple myeloma].
Abramova TV, Obukhova TN, Mendeleeva LP, Pokrovskaya OS, Gribanova EO, Ryzhko VV, Grebenyuk LA, Nareyko MV, Solovyev MV, Votyakova OM, Kulikov SM, Rusinov MA, Savchenko VG. Abramova TV, et al. Among authors: obukhova tn. Ter Arkh. 2017;89(7):32-38. doi: 10.17116/terarkh201789732-38. Ter Arkh. 2017. PMID: 28766538 Russian.
Results of program acute myeloid leukemia therapy use in National Medical Research Center for Hematology of the Ministry of Health of Russian Federation.
Parovichnikova EN, Loukianova IA, Troitskaya VV, Drokov MY, Lobaova TI, Kuzmina LA, Sokolov AN, Kokhno AV, Fidarova ZT, Baskhaeva GA, Gavrilina OA, Vasilyeva VA, Obukhova TN, Kuznetsova SA, Sudarikov AB, Dvirnik VN, Galtseva IV, Davidiva JO, Kulikov SM, Savchenko VG. Parovichnikova EN, et al. Among authors: obukhova tn. Ter Arkh. 2018 Aug 17;90(7):14-22. doi: 10.26442/terarkh201890714-22. Ter Arkh. 2018. PMID: 30701918
First experience of using Brentuximab vedotin and modified program NHL-BFM-90 in the front-line treatment of patient with anaplastic large-cell lymphoma: a case report and a review of literature.
Chernova NG, Zvonkov EE, Badmazhapova DS, Sinitsyna MN, Grebenyuk LA, Sidorova YV, Kostina IE, Kovrigina AM, Obukhova TN, Sudarikov AB, Savchenko VG. Chernova NG, et al. Among authors: obukhova tn. Ter Arkh. 2018 Aug 17;90(7):77-81. doi: 10.26442/terarkh201890777-81. Ter Arkh. 2018. PMID: 30701926 Review.
105 results